The report is about Sofosbuvir API market. Market Analysis and Insights: Global Sofosbuvir (CAS 1190307-88-0) Market The global Sofosbuvir (CAS 1190307-88-0) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Sofosbuvir (CAS 1190307-88-0) Scope and Market Size The global Sofosbuvir (CAS 1190307-88-0) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sofosbuvir (CAS 1190307-88-0) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type Purity ? 98% Purity ? 98% Segment by Application Adults Patients Elderly Patients The Sofosbuvir (CAS 1190307-88-0) market is analysed and market size information is provided by regions (countries). Segment by Application, the Sofosbuvir (CAS 1190307-88-0) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company Teva Pharmaceutical Industries Ltd DONG BANG FUTURE TECH & LIFE CO., LTD Beaukev Pharma International Pvt.Ltd DEAFARMA Tecoland Anhui HaiKang Pharmaceutical Co. Ltd Shanghai Haoyuan Chemexpress Co., Ltd Beijing Kawin Technology Share-holding Co Hangzhou Longshine Bio-Tech Co
1 Sofosbuvir (CAS 1190307-88-0) Market Overview 1.1 Sofosbuvir (CAS 1190307-88-0) Product Scope 1.2 Sofosbuvir (CAS 1190307-88-0) Segment by Type 1.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016 & 2021 & 2027) 1.2.2 Purity ? 98% 1.2.3 Purity ? 98% 1.3 Sofosbuvir (CAS 1190307-88-0) Segment by Application 1.3.1 Global Sofosbuvir (CAS 1190307-
